Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer
NCT05187416 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-01-19
Summary
Pancreatic cancer is a gastrointestinal tumor with a high degree of malignancy. Currently, there are many first-line chemotherapy regimens in clinical practice, but the individual selection of chemotherapy regimens has not been unanimously recognized.This study is aimed at exploring the correlation between the two-dimensional shear wave elastography (2D - SWE) parameters and pancreatic cancer stromal elements proportion through an ultrasound scan for resectable pancreatic cancer cases and postoperative pathological specimen analysis. Then determine if the pancreatic cancer two-dimensional shear wave elastography can guide clinicians selecting chemotherapy scheme by predicting tumor stromal elements .These results are expected to provide an effective non-invasive diagnostic basis for individualized treatment of pancreatic cancer.
Conditions
- Pancreatic Neoplasms
Interventions
- DIAGNOSTIC_TEST
-
two-dimensional shear wave elastography
Preoperative ultrasound elastography examination
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-01
- Primary Completion
- 2022-10-01
- Completion
- 2022-10-01
Countries
- China
Study Locations
More Related Trials
-
Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer
NCT02190071 ·Status: COMPLETED
-
Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center
NCT05141656 ·Status: UNKNOWN
-
Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples
NCT04246710 ·Status: ACTIVE_NOT_RECRUITING
-
Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer
NCT04699539 ·Status: COMPLETED ·Phase: NA
-
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer
NCT06108531 ·Status: ENROLLING_BY_INVITATION
-
Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.
NCT06655233 ·Status: RECRUITING
-
Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm
NCT05907824 ·Status: UNKNOWN
-
Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas
NCT05234450 ·Status: UNKNOWN
-
Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
NCT03498326 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC
NCT04794140 ·Status: UNKNOWN ·Phase: NA
-
Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy
NCT07274657 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer
NCT05438797 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823 ·Status: ACTIVE_NOT_RECRUITING
-
Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study
NCT07173374 ·Status: SUSPENDED ·Phase: PHASE1
-
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
NCT06151691 ·Status: NOT_YET_RECRUITING
-
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
NCT06849063 ·Status: RECRUITING
-
Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer
NCT05634564 ·Status: UNKNOWN ·Phase: PHASE2
-
Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
NCT04977596 ·Status: COMPLETED
-
Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer
NCT04289792 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer
NCT02017015 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 ·Status: RECRUITING
-
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
NCT05562297 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer
NCT02745847 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
NCT02283372 ·Status: COMPLETED ·Phase: PHASE1